Consolidated Financial Highlights for Q2FY27

Revenue Performance:

  • Revenue from Operations: ₹149.84 Crores, up 13% YoY from ₹133.14 Crores in Q2FY26
  • Flat quarter-on-quarter performance (0% change from Q1FY27 revenue of ₹150.53 Crores)

Profitability Metrics:

  • EBITDA: ₹13.31 Crores, up 22% YoY from ₹10.87 Crores in Q2FY26
  • EBITDA Margin: 8.88%, improved 72 basis points YoY from 8.16%
  • QoQ EBITDA declined 12% from ₹15.14 Crores in Q1FY27
  • QoQ EBITDA Margin declined 117 basis points from 10.06%
  • Profit Before Tax: ₹11.22 Crores, up 37% YoY from ₹8.21 Crores
  • Net Profit: ₹8.33 Crores, up 35% YoY from ₹6.17 Crores
  • EPS: ₹1.51, up 35% YoY from ₹1.12

Other Financial Items:

  • Other Income: ₹0.20 Crores, up 162% YoY from ₹0.08 Crores
  • Finance Cost: ₹0.64 Crores, down 48% YoY from ₹1.24 Crores and down 33% QoQ from ₹0.96 Crores
  • Depreciation: ₹1.45 Crores, up 2% YoY from ₹1.42 Crores

Half-Year Performance (H1FY27)

Revenue Performance:

  • Revenue from Operations: ₹300.36 Crores, up 10% YoY from ₹273.43 Crores in H1FY26

Profitability Metrics:

  • EBITDA: ₹28.45 Crores, up 19% YoY from ₹23.94 Crores
  • EBITDA Margin: 9.47%, improved 71 basis points YoY from 8.76%
  • Profit Before Tax: ₹23.96 Crores, up 32% YoY from ₹18.21 Crores
  • Net Profit: ₹17.80 Crores, up 31% YoY from ₹13.60 Crores
  • EPS: ₹3.23, up 31% YoY from ₹2.47

Other Financial Items:

  • Other Income: ₹0.40 Crores, up 152% YoY from ₹0.16 Crores
  • Finance Cost: ₹1.60 Crores, down 45% YoY from ₹2.90 Crores
  • Depreciation: ₹2.89 Crores, up 2% YoY from ₹2.83 Crores

Product Revenue Contribution for Q2FY27

  • Gas Treating Chemicals & Speciality Solvents: 41.77%
  • Alkanolamines and Alkyl Alkanolamines: 42.85%
  • Morpholine & Derivatives: 4.97%
  • EO/PO-Based Speciality Products: 9.16%

Management Commentary

Operational Challenges:

  • Key raw material supplies were limited for more than a month during the quarter
  • Company shifted production towards other products in the portfolio to protect revenue and margins
  • Supplies resumed in the later part of the quarter, operations have remained steady since

Market Conditions:

  • Broader environment presents challenges in availability and cost of gas
  • Elevated logistics costs with shipping rates staying high through the quarter
  • Customers worked closely to absorb resulting rise in freight costs
  • Middle East demand has stayed resilient

Research & Development:

  • Work underway on new products in ethoxylates and propoxylates categories
  • Initial commercial supplies of some products begun to select multinational customers
  • Viewed as meaningful avenue for future growth

Capital Expenditure:

  • Committed approximately ₹4 to 5 crore for ethylene oxide storage and transportation infrastructure upgrades
  • Investment will strengthen safety standards and align with regulatory requirements

Outlook:

  • Strong demand visibility and healthy order book
  • Focus remains on running operations efficiently and protecting financial performance
  • Intent to put capital into capacity and infrastructure to support next phase of growth when conditions ease
  • Resilience over past two quarters and progress on products/customers positions company well for future opportunities

Company Background

Amines & Plasticizers Limited (APL), founded in 1973 and headquartered in Mumbai, is a leading manufacturer of:

  • Ethanolamines
  • Alkyl alkanolamines
  • Morpholine derivatives
  • Gas-treating solvents

Market Position:

  • Holds 75-80% share of Indian ethanolamines market
  • Exports to over 85 countries across North America, Europe, and Asia
  • First Indian company to indigenously develop and manufacture methyl diethanolamine (MDEA)
  • Among top global producers of MEDA based solvents and Nmethyl morpholine oxide (NMMO)

Industry Segments Served:

  • Oil refining
  • Petrochemicals
  • Pharmaceuticals
  • Agrochemicals
  • Textiles

Recent Diversification:

  • Entered oilfield chemicals segment with solutions including H2S scavengers and demulsifiers

Risk Factors Disclosure

The document contains forward-looking statements with key risk factors including:

  • Volatility in key raw material and energy prices
  • Tightening of environmental, health or safety regulations
  • Currency exchange fluctuations
  • Unpredictable market demand or economic conditions